Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

The pathogenesis of atherosclerosis: a perspective for the 1990s

Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618 · see citing works

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604 · see citing works

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543 · see citing works

2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*

Guidelines Committee (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00001 · Cited by 3,015 · see citing works

2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension

Mancia, G., Rosei, E. A., Cífková, R., DeBacker, G., Erdine, S. E., Fagard, R., Farsang, C., Heagerty, A. M., Kawecka-Jaszcs, K., Kiowski, W., et al. (2003) · Lirias (KU Leuven) · doi:10.1097/01.hjh.0000059051.65882.32 · Cited by 2,601 · see citing works

Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.

Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404 · see citing works

C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men

Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952 · see citing works

Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645 · see citing works

Fibrinogen and risk of cardiovascular disease. The Framingham Study

Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387 · see citing works

The pathogenesis of atherosclerosis

(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329 · see citing works

Fibrinogen and Risk of Cardiovascular Disease

Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 894 · see citing works

Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project

Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836 · see citing works

Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

Fröhlich, M., Imhof, A., Berg‐Beckhoff, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., Muche, R., Brenner, H., & Köenig, W. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1835 · Cited by 683 · see citing works

Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes

Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652 · see citing works

Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

Schalkwijk, C., Poland, D. C. W., van Dijk, W., Kok, A., EMEIS, J. J., Dräger, A. M., Doni, A., van Hinsbergh, V. W. M., & Stehouwer, C. D. A. (1999) · Diabetologia · doi:10.1007/s001250051162 · Cited by 309 · see citing works

Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Saito, I., Folsom, A. R., Brancati, F. L., Duncan, B. B., Chambless, L. E., & McGovern, P. G. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00007 · Cited by 235 · see citing works

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

Folsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 225 · see citing works

C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis

Hashimoto, H., Kitagawa, K., Hougaku, H., Shimizu, Y., Sakaguchi, M., Nagai, Y., Iyama, S., Yamanishi, H., Matsumoto, M., & Hori, M. (2001) · Circulation · doi:10.1161/hc2601.091705 · Cited by 214 · see citing works

C-reactive protein and myocardial infarction

Sakkinen, P. A., Abbott, R. D., Curb, J. D., Rodríguez, B. L., Yano, K., & Tracy, R. P. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00502-9 · Cited by 178 · see citing works

Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes

Ganda, O. P., & Arkin, C. F. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1245 · Cited by 171 · see citing works

Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors

Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1263 · Cited by 152 · see citing works

Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes

Hayaishi-Okano, R., Yamasaki, Y., Katakami, N., Ohtoshi, K., Gorogawa, S.-I., Kuroda, A., Matsuhisa, M., Kosugi, K., Nishikawa, N., Kajimoto, Y., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1432 · Cited by 129 · see citing works

C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk

Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., EMEIS, J. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013786.80104.d4 · Cited by 128 · see citing works

Inflammation markers and coronary heart disease

Tracy, R. P. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199910000-00008 · Cited by 123 · see citing works

Fibrinogen and Cardiovascular Risk

Ernst, E., & Köenig, W. (1997) · Vascular Medicine · doi:10.1177/1358863x9700200207 · Cited by 99 · see citing works

Endothelial Progenitor Cells

Rosenzweig, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmp020175 · Cited by 82 · see citing works

Risk factors in coronary atherosclerosis athero-inflammation: the meeting point

Altman, R. (2003) · Thrombosis Journal · doi:10.1186/1477-9560-1-4 · Cited by 81 · see citing works

Influence of Plasma Fibrinogen Levels on the Incidence of Myocardial Infarction and Death Is Modified by Other Inflammation-Sensitive Proteins

Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Eriksson, K. F., & Lindgärde, F. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.452 · Cited by 72 · see citing works

Microparticle‐enhanced nephelometric immunoassay for human C‐reactive protein

Montagne, P. M., Laroche, P., Cuillière, M. L., Varcin, P., Pau, B., & Duheille, J. (1992) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860060106 · Cited by 49 · see citing works

Inflammatory Markers in Coronary Artery Disease

Vorchheimer, D. A., & Fuster, V. (2001) · JAMA · doi:10.1001/jama.286.17.2154 · Cited by 45 · see citing works

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Timon, I. M. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 982 · see citing works

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01409-0 · Cited by 198 · see citing works

Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes

Mohammad-Shahi, M., Veissi, M., Haidari, F., Shahbazian, H. B., Kaydani, G. A., & Mohammadi, F. (2014) · Europe PMC (PubMed Central) · doi:10.5681/bi.2014.007 · Cited by 118 · see citing works

Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin

Grotta, R. L., de Candia, P., Olivieri, F., Matacchione, G., Giuliani, A., Rippo, M. R., Tagliabue, E., Mancino, M., Rispoli, F., Ferroni, S., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04289-z · Cited by 118 · see citing works

Dynamic Role of Microparticles in Type 2 Diabetes Mellitus

Nomura, S. (2009) · Current Diabetes Reviews · doi:10.2174/157339909789804404 · Cited by 78 · see citing works

Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice

Madaudo, C., Coppola, G., Parlati, A. L. M., & Corrado, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116016 · Cited by 70 · see citing works

Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD

Eckel, R. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005320 · Cited by 68 · see citing works

Role of Inflammation and Infection in Vascular Disease

Corrado, E., & Novo, S. (2005) · Acta chirurgica Belgica · doi:10.1080/00015458.2005.11679782 · Cited by 60 · see citing works

Diabetes, depressive symptoms, and inflammation in older adults: Results from the Health, Aging, and Body Composition Study

Doyle, T. A., de Groot, M., Harris, T. B., Schwartz, F., Strotmeyer, E. S., Johnson, K., & Kanaya, A. M. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.08.006 · Cited by 51 · see citing works

C-reactive protein variations for different chronic somatic disorders

Håheim, L. L., Nafstad, P. H. J., Olsen, I., Schwarze, P. E., & Rønningen, K. S. (2009) · Scandinavian Journal of Public Health · doi:10.1177/1403494809104358 · Cited by 49 · see citing works

Statins and Peripheral Arterial Disease: Effects on Claudication, Disease Progression, and Prevention of Cardiovascular Events

Coppola, G., & Novo, S. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.12.012 · Cited by 44 · see citing works

Association of Elevated Fibrinogen and C-Reactive Protein Levels with Carotid Lesions in Patients with Newly Diagnosed Hypertension or Type II Diabetes

Corrado, E., Rizzo, M., Muratori, I. M., Coppola, G., & Novo, S. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.06.005 · Cited by 42 · see citing works

Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol

Rizzo, M., Corrado, E., Coppola, G., Muratori, I. M., Novo, G., & Novo, S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.020 · Cited by 42 · see citing works

Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein

Dandona, P. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.3.333 · Cited by 42 · see citing works

C-reactive protein (CRP): more than just an innocent bystander?

Paraskevas, K. I., & Mikhailidis, D. P. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253654 · Cited by 40 · see citing works

Diabetes mellitus and cerebrovascular disease: which are the actual data?

Hatzitolios, A. I., Didangelos, T., Zantidis, A., Τζιόμαλος, Κ., Giannakoulas, G. A., & Karamitsos, D. T. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.01.004 · Cited by 31 · see citing works

5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study

McKenzie, A. L., Athinarayanan, S. J., Van Tieghem, M. R., Volk, B. M., Roberts, C. G. P., Adams, R. N., Volek, J. S., Phinney, S. D., & Hallberg, S. J. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111898 · Cited by 25 · see citing works

The predictive role of C‐reactive protein in patients with hypertension and subclinical atherosclerosis

Rizzo, M., Corrado, E., Coppola, G., Muratori, I. M., Mezzani, A., Novo, G., & Novo, S. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01955.x · Cited by 24 · see citing works

Inflammatory biomarkers: impact for diabetes and diabetic vascular disease

Bosevski, M., Stojanovska, L., & Apostolopoulos, V. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv109 · Cited by 25 · see citing works

Prediction of Cerebrovascular and Cardiovascular Events in Patients with Subclinical Carotid Atherosclerosis

Rizzo, M., Corrado, E., Coppola, G., Muratori, I. M., & Novo, S. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31816204ab · Cited by 23 · see citing works

High plasma levels of endothelin-1 enhance the predictive value of preclinical atherosclerosis for future cerebrovascular and cardiovascular events

Novo, G., Sansone, A., Rizzo, M., Guarneri, F. P., Pernice, C., & Novo, S. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000121 · Cited by 21 · see citing works

Diabetic pulmonary microangiopathy - fact or fiction?

Kuziemski, K., Specjalski, K., & Jassem, E. (2011) · PubMed · Cited by 20 · see citing works

Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes

Henry, M. L., Davidson, L., Wilson, J. E., McKenna, B. K., Scott, S., McDonagh, P. F., & Ritter, L. S. (2008) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3282f41e56 · Cited by 19 · see citing works

C-reactive protein levels according to physical activity and body weight for participants in the coronary health improvement project

Merrill, R. M., Massey, M. T., Aldana, S. G., Greenlaw, R. L., Diehl, H. A., & Salberg, A. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.12.002 · Cited by 13 · see citing works

Statins and peripheral arterial disease.

Markel, A. (2015) · PubMed · Cited by 13 · see citing works

Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus

Schöndorf, T., Lübben, G., Hoopmann, M., Borchert, M., Forst, T. M., Hohberg, C., Löbig, M., Armbruster, F.-P., Roth, W., Grabellus, M., et al. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701447998 · Cited by 13 · see citing works

Evaluation of C-Reactive Protein in Primary and Secondary Prevention

Corrado, E., & Novo, S. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00023 · Cited by 12 · see citing works

Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice

Henry, M. L. M., Davidson, L., Cohen, Z., McDonagh, P. F., Nolan, P. E., & Ritter, L. S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.01.011 · Cited by 12 · see citing works

Role of curd and yogurt in establishment and progression of diabetes through protein glycation and induction of inflammation

Patil, R., Rooge, S. B., Damame, H. H., Haldavnekar, V., & Arvindekar, A. U. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100829 · Cited by 11 · see citing works

Role of quantitative chest perfusion computed tomography in detecting diabetic pulmonary microangiopathy

Kuziemski, K., Pienkowska, J. M., Słomiński, W., Specjalski, K., Dziadziuszko, K., Jassem, E., Studniarek, M., Kalicka, R., & Słomiński, J. M. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.004 · Cited by 11 · see citing works

Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein

Rizzo, M., Corrado, E., Coppola, G., Carella, A. M., Muratori, I. M., & Novo, S. (2009) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 11 · see citing works

Macrophage Inflammatory Protein-1β and Fibrinogen Are Synergistic Predictive Markers of Prognosis of Intermediate Coronary Artery Lesions

Xu, F., Lv, S., Chen, Y., Song, X., Jin, Z., Yuan, F., Zhou, Y., & Li, H. (2012) · Cardiology · doi:10.1159/000335886 · Cited by 11 · see citing works

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

Novo, G., Maniglia, D., Egle, C., Ida, M., Sutera, F., Evola, S., Filippo, F., Enrico, H., & Novo, S. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282f19ac3 · Cited by 8 · see citing works

Mikroangiopatia płucna w przebiegu cukrzycy

Kuziemski, K., Górska, L., Jassem, E., & Madej-Dmochowska, A. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27794 · Cited by 7 · see citing works

Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.

Bi, Y., Min, M., Shen, W., Deng, P., Du, Q., Dong, M., & Liu, Y. (2015) · PubMed Central · Cited by 7 · see citing works

Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.

Mańkowska‐Cyl, A., Pollak, J., & Sypniewska, G. (2006) · Europe PMC (PubMed Central) · Cited by 7 · see citing works

Changes of Plasma Total proteins, Albumin and Fibrinogen in Type 2 Diabetes mellitus- A Pilot study.

Venkataramana, G., Indira, P., & Rao, D. V. M. (2013) · Cited by 6 · see citing works

Relationship between Inflammatory Markers and New Cardiovascular Events in Patients with Acute Myocardial Infarction Who Underwent Primary Angioplasty

Franca, E. L., Caruso, M., Sansone, A., Iacona, R., Ajello, L., Mancuso, D., Castellano, F., Novo, S., & Assennato, P. (2013) · Global Journal of Health Science · doi:10.5539/gjhs.v5n4p48 · Cited by 5 · see citing works

Potential of nanoparticles and nanopolymers in treatment of age-associated diseases

Saadatpour, F., Mohammadipanah, F., Zohourian, N., & Hodjat, M. (2021) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/ac42c7 · Cited by 3 · see citing works

The spectrum of risk factors for contrast induced nephropathy in patients undergoing coronary angiography or intervention

Candela, P., Evola, S., Lunetta, M., Toia, P., Carità, P., Andolina, G., Novo, G., Assennato, P., & Novo, S. (2014) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2014.06.003 · Cited by 3 · see citing works

High levels of hsCRP are associated with carbohydrate metabolism disorder

Elba Leiva, M., Mujica, V., Brito, K., Palomo, I. F., Orrego, R., Moore‐Carrasco, R., Vásquez, M., Guzmán, L., Wehinger, S., Díaz, N. S., et al. (2011) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20455 · Cited by 3 · see citing works

The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.

Gupta, M., Teoh, H., Kajil, M., Tsigoulis, M., Quan, A., Braga, M. F. B., & Verma, S. (2012) · Europe PMC (PubMed Central) · Cited by 3 · see citing works

Individualized Cardiovascular Risk Assessment

Szabov, E. (2012) · InTech eBooks · doi:10.5772/31500 · Cited by 2 · see citing works

Study of plasma fibrinogen level in type 2 diabetes mellitus and its association with microalbuminuria and glycemic control

Saini, P. K., Saluja, M., Meena, S. R., & Meena, S. B. (2016) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2016.05.002 · Cited by 2 · see citing works

Association of Insulin Based Insulin Resistance with Liver Biomarkers in Type 2 Diabetes mellitus

Adiga, U. S., Kathyayani, P., & Nandith, P. B. (2019) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.13.2.60 · Cited by 2 · see citing works

Cardiovascular risk assessment in type 2 diabetes mellitus

Al‐Ozairi, E., Middelbeek, R. J. W., & Horton, E. S. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0001-3 · Cited by 1 · see citing works

Determination of the cut-off score of Human platelets membrane glycoprotein IIb/IIIa in COVID19: A novel biomarker and a therapeutic target

Fadel, H. H., Ahmed, M., Mohamed, M., & Almiry, R. (2021) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2021.100838.4685 · Cited by 1 · see citing works

INSULIN RESISTANCE AND HEPATIC MARKERS IN TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY

Bonam, V. R., Supriya, P., & Reddamma, P. P. (2024) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2024;12(4):886-891 · Cited by 1 · see citing works

Rassegnedella proteina C reattiva ad elevata sensibilità in prevenzione primaria

Corrado, E., & Novo, S. (2015)

Metabolic Syndrome: From the Pathophysiology to the Treatment. A Comprehensive Review

Novo, S., Bonomo, V., & Mariaconcetta, D. P. (2017) · International Journal of Sciences · doi:10.18483/ijsci.472

Study of fibrinogen levels and its association with glycemic control and albumin excretion rate in patients with type 2 diabetes mellitus

Krishna, N. (2010)

Evaluation of interleukin-6 and C - reactive protein as a inflammatory mediators in type 2 diabetic subjects in Indian population of Bhopal

Hisalkar, P., Patne, A., & Dubey, A. (2022) · Panacea Journal of Medical Sciences · doi:10.18231/j.pjms.2022.064

Additional file 1 of Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Sharif, S., van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., & Westerink, J. (2021) · Figshare · doi:10.6084/m9.figshare.16969304

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Al-Sharify, D., Sun, J., & Edsfeldt, A. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70118

EFFECTS OF OBESITY AND TYPE 2 DIABETES ON MOUSE PLATELET AND PMN LEUKOCYTE MARKERS OF ACTIVATION

Maes, M. (2006) · UA Campus Repository (The University of Arizona)

Assessment of c-reactive protein and fibrinogen levels in type 2 diabetes mellitus

Iyer, U. M., & Desai, P. A. (2010) · Biomedical Research-tokyo · Cited by 3 · see citing works

A Study of Fibrinogen Level and C-reactive Protein in Type 1 and Type 2 Diabetes Mellitus and Their Relation to Glycemic Control

Alnour, M. S. M., & Abdalla, M. H. A. (2015) · American Journal of Medicine and Medical Sciences · Cited by 1 · see citing works

Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus.

Tsuruda, T., Kato, J., Sumi, T., Mishima, K., Masuyama, H., Nakao, H., Imamura, T., Eto, T., & Kitamura, K. (2007) · PubMed Central · Cited by 2 · see citing works

C-Reactive Protein and Incident Cardiovascular Events Among Men With Diabetes

Schulze, M. B., Rimm, E. B., Li, T., Rifai, N., Stampfer, M. J., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.889 · Cited by 180 · see citing works

Evaluation of plasma fibrinogen, D‐dimer and C‐reactive protein as predictive parameters for coronary heart diseases in type 2 diabetic patients

Muhsin, N. A., & Al-Mudallal, S. S. (2018) · Mustansiriya Medical Journal · Cited by 1 · see citing works